Assessing the relationship between environmental enteric dysfunction and poor growth via a newly developed 11-plex assay
通过新开发的 11 重检测评估环境肠道功能障碍与生长不良之间的关系
基本信息
- 批准号:10021657
- 负责人:
- 金额:$ 18.52万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-21 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:5 year oldAdultAffectAgeAge-MonthsAssessment toolBiological AssayBiological MarkersBiological SciencesBirthBirth WeightBirth lengthBloodC-reactive proteinCD14 geneCaregiversChildChild MortalityChildhoodCholecalciferolChronicClinic VisitsCognitiveDataDevelopmentEconomicsEnrollmentEnteralEnvironmentEnvironmental EpidemiologyExposure toFailureFerritinFlagellinFunctional disorderGrowthGrowth and Development functionHIVHealthHeightHistologicHuman DevelopmentHygieneHypertensionImmunoglobulinsIndividualInfantInflammationInsulin-Like Growth Factor IIntestinal permeabilityIntestinesKnowledgeLanguageLengthLifeLinkLipopolysaccharidesLongitudinal cohort studyMalnutritionMeasuresMethodsMicronutrientsMorbidity - disease rateMothersMotorMucositisOrosomucoidOutcomePermeabilityPersonal SatisfactionPlasmodium falciparumPopulationPostpartum PeriodPregnancyPregnant WomenProductivityRBP4 geneRandomizedReportingResearchRiskRoleSamplingSerumSeveritiesSmall IntestinesSomatotropinStandardizationSupplementationSurrogate MothersTFRC geneTanzaniaThyroglobulinTimeVillousVitaminsabsorptionadverse birth outcomesbaseburden of illnesscholecalciferol supplementationcognitive developmentdouble-blind placebo controlled trialenteric pathogenfibroblast growth factor 21gastrointestinalhormone resistanceimprovedin uteroindexinginfancyinflammatory disease of the intestineinnovationintestinal fatty acid binding proteinlow and middle-income countriesmicrobialmortalityneurodevelopmentnutritionscreeningwork-study
项目摘要
Project Summary:
Undernutrition remains one of the greatest human development challenges of our time. In 2017, an
estimated 151 million children < 5 years of age (i.e., 22.2% of the global population) were stunted, increasing
their risk for morbidity and mortality in childhood, suboptimal cognitive development, poorer educational
outcomes, and lower economic productivity and earnings in adulthood. It has been increasingly appreciated
that growth failure can begin in utero and worsen during early infancy; recently, environmental enteric
dysfunction (EED) has been hypothesized as an important causal factor. EED is an acquired, subclinical
condition of the small intestine associated with chronic exposure to an unhygienic environment where enteric
pathogens persist. Histologic features include mucosal inflammation, villous blunting, altered barrier integrity,
and reduced intestinal absorptive capacity. Despite EED’s purported link to poor health and nutrition outcomes
in young children in low- and middle- income countries (LMICs), our knowledge of EED is relatively limited.
Research gaps include the role of infant EED on subsequent poor growth and development and the possible
role of maternal EED on adverse birth outcomes.
The Trial of Vitamins-5 (ToV5) is an individually randomized, double-blind, placebo-controlled trial (R01
HD83113; ClinicalTrials.gov: NCT02305927) of maternal vitamin D3 (cholecalciferol) supplementation
conducted among 2,300 HIV-infected pregnant women in Dar es Salaam, Tanzania. Following enrollment into
the trial, mothers were followed-up at monthly clinic visits during pregnancy, at delivery, and then with their
child at monthly postpartum clinic visits. Using data and serum samples collected in the ToV5 study, the main
objectives of the current proposal are to assess 1) the relationship between infant EED and linear growth, i.e.,
length-for-age Z-score (LAZ) at 12 months of age; 2) the relationship between infant EED and development,
measured by the Caregiver-Reported Early Development Index (CREDI) at 12 months of age; and 3) the
relationship between maternal EED during pregnancy and birth outcomes, primarily infant birth weight and
duration of gestation. We also aim to 4) examine relationships between the EED, systemic inflammation, and
micronutrient biomarkers from a newly developed 11-plex multi-micronutrient and EED assessment tool
(MEEDAT); consisting of intestinal fatty acid–binding protein (I-FABP), soluble CD14 (sCD14), insulin-like
growth factor 1 (IGF-1), fibroblast growth factor 21 (FGF21), alpha-1-acid glycoprotein (AGP), C-reactive
protein (CRP), ferritin, soluble transferrin receptor (sTfR), retinol binding protein 4 (RBP4), thyroglobulin (Tg),
and Plasmodium falciparum exposure (HRP2); and anti-flagellin/anti-LPS Igs. Overall, this proposed research
will contribute to our understanding of the consequences of EED in LMICs, specifically related to poor growth
and adverse birth outcomes, using two innovative methods for assessing EED, namely anti-flagellin/anti-LPS
Igs and MEEDAT.
项目概要:
营养不良仍然是我们时代人类发展面临的最大挑战之一。2017年,
估计有1.51亿5岁以下儿童(即,全球人口的22.2%)发育迟缓,
儿童期发病率和死亡率的风险,认知发育欠佳,教育程度较低,
结果,以及成年后较低的经济生产力和收入。人们越来越认识到,
生长障碍可在子宫内开始,并在婴儿早期恶化;最近,环境肠道
功能障碍(EED)已被假设为一个重要的致病因素。EED是一种获得性亚临床
与长期暴露于不卫生的环境相关的小肠状况,
病原体持续存在。组织学特征包括粘膜炎症、绒毛钝化、屏障完整性改变,
和降低的肠吸收能力。尽管EED据称与健康和营养不良有关,
在低收入和中等收入国家的幼儿中,我们对EED的了解相对有限。
研究差距包括婴儿EED对随后不良生长和发育的作用以及可能的
产妇EED对不良出生结局的作用。
Vitamin-5试验(ToV 5)是一项个体随机、双盲、安慰剂对照试验(R 01
HD 83113; ClinicalTrials.gov:NCT 02305927)补充母体维生素D3(胆钙化醇)
在坦桑尼亚达累斯萨拉姆的2 300名感染艾滋病毒的孕妇中进行。入组后,
在这项试验中,母亲们在怀孕期间,分娩时每月进行一次门诊随访,然后与他们的
每月产后门诊就诊。使用ToV 5研究中收集的数据和血清样本,
目前建议的目的是评估1)婴儿EED和线性生长之间的关系,即,
12月龄时的年龄别身长Z评分(LAZ); 2)婴儿EED与发育之间的关系,
在12个月龄时通过看护者报告的早期发育指数(CREDI)测量;以及3)
妊娠期母体EED与出生结局(主要是婴儿出生体重)之间的关系,
妊娠期。我们还旨在4)检查EED,全身炎症,
来自新开发的11重多重微量营养素和EED评估工具的微量营养素生物标志物
(MEEDAT);由肠脂肪酸结合蛋白(I-FABP)、可溶性CD 14(sCD 14)、胰岛素样
生长因子1(IGF-1),成纤维细胞生长因子21(FGF 21),α-1-酸性糖蛋白(AGP),C-反应性
蛋白质(CRP)、铁蛋白、可溶性转铁蛋白受体(sTfR)、视黄醇结合蛋白4(RBP 4)、甲状腺球蛋白(Tg),
和恶性疟原虫暴露(HRP 2);和抗鞭毛蛋白/抗LPS Ig。总的来说,这项研究
将有助于我们理解低收入国家EED的后果,特别是与增长不良有关的后果
和不良出生结局,使用两种创新方法评估EED,即抗鞭毛蛋白/抗LPS
Igs和MEEDAT。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CHRISTOPHER P DUGGAN其他文献
CHRISTOPHER P DUGGAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CHRISTOPHER P DUGGAN', 18)}}的其他基金
Trial of Zinc Supplements for Young Infants with Clinical Severe Infection in Tanzania
在坦桑尼亚对患有临床严重感染的小婴儿进行锌补充剂试验
- 批准号:
10635077 - 财政年份:2023
- 资助金额:
$ 18.52万 - 项目类别:
Patient-oriented Research in Pediatric Diarrheal Diseases
以患者为中心的小儿腹泻病研究
- 批准号:
8680269 - 财政年份:2010
- 资助金额:
$ 18.52万 - 项目类别:
Patient-oriented Research in Pediatric Diarrheal Diseases
以患者为中心的小儿腹泻病研究
- 批准号:
8294784 - 财政年份:2010
- 资助金额:
$ 18.52万 - 项目类别:
Patient-oriented Research in Pediatric Diarrheal Diseases
以患者为中心的小儿腹泻病研究
- 批准号:
8471737 - 财政年份:2010
- 资助金额:
$ 18.52万 - 项目类别:
Patient-oriented Research in Pediatric Diarrheal Diseases
以患者为中心的小儿腹泻病研究
- 批准号:
8113298 - 财政年份:2010
- 资助金额:
$ 18.52万 - 项目类别:
Patient-oriented Research in Pediatric Diarrheal Diseases
以患者为中心的小儿腹泻病研究
- 批准号:
7892835 - 财政年份:2010
- 资助金额:
$ 18.52万 - 项目类别:
Patient-oriented Research in Pediatric Diarrheal Diseases
以患者为中心的小儿腹泻病研究
- 批准号:
9115582 - 财政年份:2008
- 资助金额:
$ 18.52万 - 项目类别:
Randomized trial of vitamin B12 in pregnant Indian women
印度孕妇维生素 B12 的随机试验
- 批准号:
7231556 - 财政年份:2007
- 资助金额:
$ 18.52万 - 项目类别:
NUTRITION SUPPORT IN PEDIATRIC STEM CELL TRANSPLANTATION - A RCT
儿科干细胞移植中的营养支持 - 随机对照试验
- 批准号:
7607255 - 财政年份:2007
- 资助金额:
$ 18.52万 - 项目类别:
A Trial of Zinc and Micronutrients in Tanzanian Children
坦桑尼亚儿童的锌和微量营养素试验
- 批准号:
7270675 - 财政年份:2006
- 资助金额:
$ 18.52万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 18.52万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 18.52万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 18.52万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 18.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 18.52万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 18.52万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 18.52万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 18.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 18.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 18.52万 - 项目类别:
Grant-in-Aid for Scientific Research (C)